U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06883240) titled 'An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment' on March 13.

Brief Summary: This non-interventional study (NIS) is designed to collect information on the effectiveness and safety of treatment received in routine clinical care, as well as measure the health-related quality of life (HRQoL) of participants with Type 3 von Willebrand disease (VWD) receiving prophylactic therapy per local standard of care (SOC) over an observation period of at least 24 weeks.

Study Start Date: April 14

Study Type: OBSERVATIONAL

Condition: Von Willebrand Disease, Type 3

Interventi...